IP Verse

Toolgen Incorporated competitive analysis

Loading summary...

Latest patents of Toolgen Incorporated opposed by its competitors

Explore Toolgen Incorporated's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 6, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP4357457
Oct 16, 2024Composition For Cleaving A Target Dna Comprising A Guide Rna Specific For The Target Dna And Cas Protein-Encoding Nucleic Acid Or Cas Protein, And Use Thereof3
EP3733847
Jun 1, 2022Composition For Cleaving A Target Dna Comprising A Guide Rna Specific For The Target Dna And Cas Protein-Encoding Nucleic Acid Or Cas Protein, And Use Thereof5
EP3346003
Jun 9, 2021Composition For Cleaving A Target Dna Comprising A Guide Rna Specific For The Target Dna And Cas Protein-Encoding Nucleic Acid Or Cas Protein, And Use Thereof3
EP2912175
Aug 22, 2018Composition For Cleaving A Target Dna Comprising A Guide Rna Specific For The Target Dna And Cas Protein-Encoding Nucleic Acid Or Cas Protein, And Use Thereof6

Latest PTAB cases involving Toolgen Incorporated

Discover the latest PTAB cases involving Toolgen Incorporated, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Toolgen Incorporated with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 6, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
TOOLGEN INCORPORATED - 17 - -
CRISPR THERAPEUTICS12 - - -
GRUND32 - - -
SCHLICH32 - - -